Project Grant R35GM158052
Award Date
6/1/25
Completion Date
5/31/30
Dollars Obligated
$424K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $313,520 Project Grant (CFDA 93.859 Biomedical Research and Research Training) to the Regents of the University of Michigan to develop the RNP-MAP (RNA-Protein Networks Analyzed by Mutational Profiling) technology into a comprehensive toolset. This project aims to create novel live-cell chemical probing methods to 1) map multi-protein networks on RNA, 2) identify RNA-binding protein targets and measure RNA site-specific...
The National Human Genome Research Institute (NHGRI) awarded a $409,699 Project Grant (CFDA 93.172 - Human Genome Research) to the Regents of the University of Michigan on July 1, 2024. The grant, titled "INTEGRATING LC-MS/MS AND NANOPORE SEQUENCING PLATFORMS TO ENABLE THE DIRECT AND QUANTATATIVE DETECTION OF RNA MODIFICATIONS", will support research to develop methods for the quantitative detection of RNA modifications using a combination of liquid chromatography-tandem mass...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $1,084,158 to the Regents of the University of Michigan to support research on chemical biology approaches for investigating RNA-protein interactions (RPIs). The key objectives of this 5-year project are to: 1) Further develop and scale up the University's live-cell RPI assay technology called RNA Interaction with...
This $387,500 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research to develop improved computational methods for human gene annotation. The project aims to enhance the accuracy and completeness of the human gene catalog by leveraging massive RNA sequencing datasets and developing new algorithms to process and analyze this data at scale. Key objectives include identifying...
This $502,479 Project Grant was awarded on September 16, 2024 by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant supports research conducted by the Regents of the University of Michigan to identify and encourage connections among data reuse, scientific innovation, and scientific careers. The research aims to advance understanding in areas such as molecular biology, genetics, biochemistry, and...
This federal Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), will support research to investigate the mechanisms of transcriptional regulation in mammalian cells under stress conditions. The $374,979 award, effective June 25, 2024 through May 31, 2029, will enable the Regents of the University of Michigan to study two key gene regulatory processes: 1) the formation and...
This federal Project Grant award, valued at $215,088.00 and made by the National Human Genome Research Institute (NHGRI) under the Human Genome Research (CFDA 93.172) program, supports the development of an innovative "next-generation mass spectrometry-based sequencing (NGMS-SEQ)" method for exhaustive de novo sequencing of all RNA species in a sample. The award aims to 1) further develop the NGMS-SEQ approach to directly identify and sequence every RNA molecule, including...
This National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) Project Grant award of $350,000 aims to develop a neural network-accelerated DNA and RNA sequence processing node, called CLEDGESEQ, for field, clinical, and industrial use. The project seeks to create advanced sequence analysis and communication capabilities for Edge applications to improve the speed and accuracy of detecting biological contaminants. The two specific...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $445,000.00 to The Children's Hospital of Philadelphia (CHOP) to develop technologies to delineate haplotype-resolved, full-length transcriptomes in bulk tissues and single cells, characterize transcript isoforms of haploinsufficient genes to discover novel therapeutic targets, and establish a program for RNA-guided...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $159,803 to the Regents of the University of Michigan to incorporate emerging multiomics technologies, including long-read and methylation sequencing, into the MI-ONCOSEQ CLIA precision oncology laboratory. The goal is to enhance the analysis of advanced, rare, and pediatric cancers and translate the findings into clinically actionable information through the development...